Semi-Annual Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7586205

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Semi-annual consolidated statement of income
Statement of income
Net sales
309,158,000 JPY
315,893,000 JPY
Cost of sales
19,008,000 JPY
14,441,000 JPY
Ordinary profit (loss)
-239,408,000 JPY
-105,915,000 JPY
Gross profit (loss)
290,149,000 JPY
301,451,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
541,671,000 JPY
415,820,000 JPY
Operating profit (loss)
-251,521,000 JPY
-114,369,000 JPY
Profit (loss) before income taxes
-239,408,000 JPY
-105,915,000 JPY
Non-operating income
Interest income
25,000 JPY
21,000 JPY
Non-operating income
38,789,000 JPY
13,255,000 JPY
Income taxes - current
1,196,000 JPY
1,196,000 JPY
Non-operating expenses
Interest expenses
2,465,000 JPY
3,440,000 JPY
Non-operating expenses
26,677,000 JPY
4,801,000 JPY
Income taxes
1,196,000 JPY
1,196,000 JPY
Profit (loss)
-240,605,000 JPY
-107,112,000 JPY
Profit (loss) attributable to non-controlling interests
-14,138,000 JPY
-5,201,000 JPY
Profit (loss) attributable to owners of parent
-226,467,000 JPY
-101,910,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-338,000 JPY
JPY
Other comprehensive income
-338,000 JPY
JPY
Comprehensive income
-240,943,000 JPY
-107,112,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-226,805,000 JPY
-101,910,000 JPY
Comprehensive income attributable to non-controlling interests
-14,138,000 JPY
-5,201,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.